 Connection
Ahmet Aydin to Antineoplastic Agents
This is a "connection" page, showing publications Ahmet Aydin has written about Antineoplastic Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.267 |
|
|
|
-
Goktas Aydin S, Aydin A, Cakan Demirel B, Demir O, Bayramgil A, Kutlu O, Yildirim C, Aksoy A, Gulturk I, Taskaynatan H, Tasci ES, Koseoglu C. A multicenter prospective matched comparative study on osteoporosis risk in cancer patients receiving chemotherapy. Support Care Cancer. 2025 Nov 12; 33(12):1053.
Score: 0.133
-
Hajiran A, Zemp L, Aydin AM, Cheryian SK, Pow-Sang JM, Chahoud J, Spiess PE. Topical chemotherapy for penile carcinoma in situ: Contemporary outcomes and reported toxicity. Urol Oncol. 2021 01; 39(1):72.e1-72.e5.
Score: 0.093
-
Azizi M, Aydin AM, Hajiran A, Lai A, Kumar A, Peyton CC, Minhas S, Sonpavde GP, Chahoud J, Pagliaro LC, Necchi A, Spiess PE. Systematic Review and Meta-Analysis-Is there a Benefit in Using Neoadjuvant Systemic Chemotherapy for Locally Advanced Penile Squamous Cell Carcinoma? J Urol. 2020 06; 203(6):1147-1155.
Score: 0.022
-
Boegemann M, Aydin AM, Bagrodia A, Krabbe LM. Prospects and progress of immunotherapy for bladder cancer. Expert Opin Biol Ther. 2017 11; 17(11):1417-1431.
Score: 0.019
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|